Nasdaq · CIK 0001372299
OCGN Ocugen, Inc.
Insider trading from SEC Form 4. Last filing 31 d ago. Close $0.96 on Oct 9, 2026, 0% from the 52-week low and -61% from the high.
Last 90 days
Net insider value
-$589k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$589k by 1 insider
Insiders on file
7
with a Form 4 at this company
Price and insider trades, last year
OCGNOct 9, 2026 · close 0.96
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Ocugen, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 29Weak | Shankar Musunuri Chief Executive Officer sell | $589k 525,991 shares | -11% | - | |
| 31Weak | Prabhavathi Fernandes director buy | $9,095 10,000 shares | - | - | |
| 33Weak | Kirsten Castillo director buy | $23k 25,000 shares | +50% | - |
Transactions
The last 9 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Shankar Musunuri Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -468,727 | $1.12 | $525k | 4,487,197 | 31 d ago |
| Sep 9, 2026 | Shankar Musunuri Chief Executive Officer | SOpen-market sale Common Stockindirect: By: KVM Holdings, LLC10b5-1 | -57,264 | $1.12 | $64k | 1,088,035 | 31 d ago |
| Jun 5, 2025 | Kirsten Castillo director | AGrant or award Option (Right to Buy)derivative | +151,316 | $0.00 | $0 | 151,316 | Jun 9, 2025 |
| Jun 5, 2025 | Satishchandran Chandrasekhar director | AGrant or award Option (Right to Buy)derivative | +151,316 | $0.00 | $0 | 151,316 | Jun 9, 2025 |
| Jun 5, 2025 | Blaise Coleman director | AGrant or award Option (Right to Buy)derivative | +151,316 | $0.00 | $0 | 151,316 | Jun 9, 2025 |
| Jun 5, 2025 | Uday Kompella director | AGrant or award Option (Right to Buy)derivative | +151,316 | $0.00 | $0 | 151,316 | Jun 9, 2025 |
| Jun 5, 2025 | Junge Zhang director | AGrant or award Option (Right to Buy)derivative | +151,316 | $0.00 | $0 | 151,316 | Jun 9, 2025 |
| Nov 26, 2024 | Prabhavathi Fernandes director | POpen-market purchase Common Stock | +10,000 | $0.91 | $9,095 | 10,000 | Dec 2, 2024 |
| Nov 22, 2024 | Kirsten Castillo director | POpen-market purchase Common Stock | +25,000 | $0.91 | $23k | 75,000 | Nov 26, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Kirsten Castillodirector
- Satishchandran Chandrasekhardirector
- Blaise Colemandirector
- Prabhavathi Fernandesdirector
- Uday Kompelladirector
- Shankar MusunuriChief Executive Officer
- Junge Zhangdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.